We came across a bullish thesis on Harrow, Inc. on MVC Investing’s Substack by M. V. Cunha. In this article, we will summarize the bulls’ thesis on HROW. Harrow, Inc.'s share was trading at $47.84 as of January 12th. HROW’s trailing and forward P/E were 9.64 and 44.25  respectively according to Yahoo Finance. massimofusaro/Shutterstock.com Harrow, Inc., an eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products. HROW has quietly ...